NCT04480775View on ClinicalTrials.gov

Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

December 15, 2020

Conditions
Major Abdominal Surgery
Interventions
DRUG

Triamcinolone

transversus abdominis plane block with bupivacain and triamicinolone

DRUG

Methylprednisolone

transversus abdominis plane block with bupivacaine and methylprednisolone

DRUG

bupivacaine

transversus abdominis plane block with bupivacaine alone

Trial Locations (1)

Unknown

Mansoura University, Al Mansurah

All Listed Sponsors
lead

ghada fouad

OTHER

NCT04480775 - Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block | Biotech Hunter | Biotech Hunter